Sight Sciences, Inc. cotiza a 8.97 USD y tiene una capitalización bursátil de $494M. En los últimos 12 meses ha facturado $83M con un margen de flujo de caja libre del -38.7%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system f…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.08 | $-0.24 | $-0.08 |
| Estimado | $-0.13 | $-0.14 | $-0.20 | $-0.14 |
| Sorpresa | — | +42.9% | -20.0% | +42.9% |
| Métrica | SGHT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 86.2% | 57.0% | +29.1% |
| Operating Margin | -48.0% | -38.6% | -9.3% |
| Net Margin | -49.7% | -33.6% | -16.1% |
| FCF Margin | -38.7% | -13.9% | -24.8% |
| ROE | -60.1% | -40.4% | -19.7% |
| ROA | -33.3% | -32.0% | -1.3% |
| Current Ratio | 10.22 | 2.84 | +7.38 |
| Debt / Equity | 0.66 | 0.28 | +0.38 |